Consolidated Statements of Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 26, 2021	Dec. 27, 2020	Dec. 26, 2021	Dec. 27, 2020
Consolidated Statements of Income (Loss)
Revenues	$ 102,462,400	$ 99,237,600	$ 315,954,700	$ 284,607,600
Cost of goods sold	82,841,600	81,921,900	256,852,000	233,718,000
Gross profit	19,620,800	17,315,700	59,102,700	50,889,600
Selling, general and administrative expenses	19,403,800	23,606,800	62,038,600	65,927,100
Operating income (loss)	217,000	(6,291,100)	(2,935,900)	(15,037,500)
Interest expense, net	131,000	151,200	503,400	367,800
Income (loss) from continuing operations before income taxess	86,000	(6,442,300)	(3,439,300)	(15,405,300)
Provision for (benefit from) income taxes	(1,129,000)	(740,400)	(1,166,200)	(1,886,600)
Net income (loss) from continuing operations	1,215,000	(5,701,900)	(2,273,100)	(13,518,700)
Income (loss) from discontinued operations, net of taxes	243,800	4,787,500	1,187,900	7,706,000
Net income (loss)	$ 1,458,800	$ (914,400)	$ (1,085,200)	$ (5,812,700)
Basic (loss) income per share
Continuing operations (in dollars per share)	$ 0.14	$ (0.66)	$ (0.26)	$ (1.56)
Discontinued operations (in dollars per share)	0.03	0.55	0.13	0.89
Consolidated operations (in dollars per share)	0.16	(0.11)	(0.12)	(0.67)
Diluted (loss) income per share
Continuing operations (in dollars per share)	0.14	(0.66)	(0.26)	(1.56)
Discontinued operations (in dollars per share)	0.03	0.55	0.13	0.89
Consolidated operations (in dollars per share)	$ 0.16	$ (0.11)	$ (0.12)	$ (0.67)
Basic weighted-average common shares outstanding (in shares)	8,957,502	8,699,937	8,910,857	8,658,205
Effect of dilutive options and other equity instruments (in shares)	39,335
Diluted weighted-average common shares outstanding (in shares)	8,996,837	8,699,937	8,910,857	8,658,205